Lexence

Lexence has assisted management (Ultra Participation B.V.) with the sale of its shares in Kadans Holding B.V. and the subsequent reinvestment in Life Science One B.V. (purchaser)

January 20, 2021 – AXA Investment Managers – Real Assets (“AXA IM – Real Assets”), a global leader in real asset investments and the leading real estate portfolio and asset manager in Europe, has acquired Kadans business, on behalf of its clients through its portfolio company Life Science One B.V., from funds advised by Oaktree Capital Management L.P.

The acquisitions provides Kadans the unique opportunity to strengthen its position as leader in the European life science and lab offices sector.

Lexence has assisted management (Ultra Participation B.V.) with the sale of its shares in Kadans Holding B.V. and the subsequent reinvestment in Life Science One B.V. (purchaser)

Key contacts Wouter Helder
Expertise Corporate/M&A
Reading time < 1 min leestijd